Anixa Biosciences Advances Breast Cancer Vaccine and CAR-T Programs
August 24, 2026 | San Jose, California Anixa Biosciences announced that it will present updates on its breast cancer...
Moffitt Cancer Center
Advertisement
Anixa Biosciences Advances Ovarian Cancer CAR-T to Highest Dose
SAN JOSE, California, July 6, 2026 Anixa Biosciences, Inc. and Moffitt Cancer Center have announced a significant milestone in...
Anixa Biosciences Reports Positive Phase 1 Cancer Vaccine Data
June 26, 2026 | San Jose, California, USA Anixa Biosciences, Inc. announced encouraging clinical updates from its two leading...
Anixa’s FSHR-Targeted CAR-T Shows Positive Safety, Patients Surpass Median Survival
Anixa Biosciences, Inc. (NASDAQ: ANIX), in partnership with Moffitt Cancer Center, announced the completion of dosing in the fourth...
Advertisement
